These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

168 related items for PubMed ID: 16521187

  • 1. Microproteinuria in patients with inflammatory bowel disease: is it associated with the disease activity or the treatment with 5-aminosalicylic acid?
    Poulou AC, Goumas KE, Dandakis DC, Tyrmpas I, Panagiotaki M, Georgouli A, Soutos DC, Archimandritis A.
    World J Gastroenterol; 2006 Feb 07; 12(5):739-46. PubMed ID: 16521187
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Minimal renal dysfunction in inflammatory bowel disease is related to disease activity but not to 5-ASA use.
    Herrlinger KR, Noftz MK, Fellermann K, Schmidt K, Steinhoff J, Stange EF.
    Aliment Pharmacol Ther; 2001 Mar 07; 15(3):363-9. PubMed ID: 11207511
    [Abstract] [Full Text] [Related]

  • 4. Renal tubular damage: an extraintestinal manifestation of chronic inflammatory bowel disease.
    Kreisel W, Wolf LM, Grotz W, Grieshaber M.
    Eur J Gastroenterol Hepatol; 1996 May 07; 8(5):461-8. PubMed ID: 8804875
    [Abstract] [Full Text] [Related]

  • 5. Comparison of outcomes of continuation/discontinuation of 5-aminosalicylic acid after initiation of anti-tumor necrosis factor-alpha therapy in patients with inflammatory bowel disease.
    Choi YI, Kim TJ, Park DK, Chung JW, Kim KO, Kwon KA, Kim YJ.
    Int J Colorectal Dis; 2019 Oct 07; 34(10):1713-1721. PubMed ID: 31471699
    [Abstract] [Full Text] [Related]

  • 6. Cancer risk and chemoprevention in Chinese inflammatory bowel disease patients: a population-based cohort study.
    Mak JWY, So J, Tang W, Yip TCF, Leung WK, Li M, Lo FH, Ng KM, Sze SF, Leung CM, Tsang SWC, Shan EHS, Chan KH, Lam BCY, Hui AJ, Chow WH, Chan FKL, Ng SC.
    Scand J Gastroenterol; 2020 Mar 07; 55(3):279-286. PubMed ID: 32119788
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Vitamin D levels and bone metabolism in Chinese adult patients with inflammatory bowel disease.
    Tan B, Li P, Lv H, Li Y, Wang O, Xing XP, Qian JM.
    J Dig Dis; 2014 Mar 07; 15(3):116-23. PubMed ID: 24354597
    [Abstract] [Full Text] [Related]

  • 9. Renal effects of long-term treatment with 5-aminosalicylic acid.
    Patel H, Barr A, Jeejeebhoy KN.
    Can J Gastroenterol; 2009 Mar 07; 23(3):170-6. PubMed ID: 19319380
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Continuing or stopping 5-aminosalicylates in patients with inflammatory bowel disease on anti-TNF therapy: A nationwide population-based study.
    Seo J, Kim S, Hong SW, Hwang SW, Park SH, Yang DH, Byeon JS, Myung SJ, Yang SK, Kim YJ, Ye BD.
    Aliment Pharmacol Ther; 2024 Aug 07; 60(3):389-400. PubMed ID: 38866064
    [Abstract] [Full Text] [Related]

  • 14. Serum inter-alpha-trypsin inhibitor heavy chain 4 in patients with inflammatory bowel disease: correlation with disease risk, inflammation, activity, and its variation after treatment.
    Wen N, Zhao N, Xu H, Zhao Y, Ma J.
    Ir J Med Sci; 2022 Oct 07; 191(5):2105-2111. PubMed ID: 34843071
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Association of extraintestinal manifestations and anaemia with disease outcomes in patients with inflammatory bowel disease.
    Vegh Z, Kurti Z, Gonczi L, Golovics PA, Lovasz BD, Szita I, Balogh M, Pandur T, Vavricka SR, Rogler G, Lakatos L, Lakatos PL.
    Scand J Gastroenterol; 2016 Jul 07; 51(7):848-54. PubMed ID: 26880133
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Crohn's disease and ulcerative colitis. Occurrence, course and prognosis during the first year of disease in a European population-based inception cohort.
    Burisch J.
    Dan Med J; 2014 Jan 07; 61(1):B4778. PubMed ID: 24393595
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.